Results 181 to 190 of about 1,259,950 (219)

Diagnostic Performance of AFP, PIVKA-II, and the ASAP Score for Distinguishing Hepatocellular Carcinoma With and Without Portal Vein Tumor Thrombus: A Retrospective Single-Center Study From Pakistan. [PDF]

Cureus
Ashraf I, Khan ME, Naqvi SAR, Imran MB, Jabbar T.   +4 more
europepmc   +1 more source

Interventional Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus and Secondary Deep Venous Thrombosis: A Case Report. [PDF]

Cancer Manag Res
Liu J, He K, Luo Z, Xiong J, Cao Y, Yin W, Yue K, Hua R.   +7 more
europepmc   +1 more source

TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula. [PDF]

J Hepatocell Carcinoma
Liu X, Yin L, Liu B, Hou X, Li Y, Liu R.
europepmc   +1 more source

Survival outcomes of intensity-modulated radiotherapy combined with immunotherapy and targeted therapy for hepatocellular carcinoma with classification I-IV portal vein tumor thrombus: a propensity score matching study. [PDF]

Front Immunol
Chen L, Wei C, Xiao Z, Wu Q, Li L, Xiang B, Guan S, Zhao P, Liang S, Li J.   +9 more
europepmc   +1 more source

Giant renal hilar angiomyolipoma with Mayo level II venous tumor thrombus: a rare case report and literature review. [PDF]

BMC Urol
Pan W, Li Y, Fan C, Hu P, Mi H.
europepmc   +1 more source

Survival benefits of non-surgical triple therapy in hepatocellular carcinoma with inferior vena cava/right atrial tumor thrombus: A retrospective analysis from a multidisciplinary team. [PDF]

Oncol Lett
Tang P, Li J, Duan J, Wang X, Zhou J, Yang Y, Zeng Y.   +6 more
europepmc   +1 more source

A rare but fatal outcome is hepatocellular carcinoma (HCC) progressing to the right atrial tumor thrombus and inferior vena cava. [PDF]

Radiol Case Rep
Hoai LT, Ngoc ADT, Hoang NV, Van Phuong NN, Van Tho V, Luan VD.   +5 more
europepmc   +1 more source

Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial. [PDF]

Front Immunol
Liang X, Li Y, Liang M, Zeng Z, Hu K, Yang L, Yan H, Li M, Zeng J, Tang J, Lv Y, Liang L, Meng J, Su H, Ma J, Mo N.   +15 more
europepmc   +1 more source

Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched Analysis. [PDF]

Liver Cancer
Gao F, Guo C, Chen Y, Shen Y, Li X, Zhang X, Gao S, Bai X, Liang T.   +8 more
europepmc   +1 more source

HAIC-Based versus TACE-Based Triple Therapy with Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Propensity Score-Matched Study. [PDF]

J Hepatocell Carcinoma
Yu J, Xu Y, Shen X, Wang J, Shao T, Wu Y, Hu H, Cheng Q, Zhang Z.   +8 more
europepmc   +1 more source